http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105001101-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C215-68
filingDate 2015-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105001101-B
titleOfInvention A kind of synthetic method of the trifluoroacetyl aniline hydrate hydrochloride of 4 chlorine 2
abstract The present invention relates to a kind of synthetic method of efavirenz intermediate, and in particular to a kind of synthetic method of the trifluoroacetyl aniline hydrate hydrochloride of 4 chlorine 2, belongs to pharmaceutical intermediate synthesis technical field.Synthetic method comprises the following steps:N-butyllithium solution is added drop-wise in 4 chlorine N pivaloyl group aniline solutions under low temperature; reaction obtains double lithium salt solutions of 4 chlorine N pivaloyl group aniline; then trifluoro-acetyl chloride gas reaction is passed through under low temperature into solution and obtains the trifluoroacetyl group N pivaloyl group aniline of 4 chlorine 2, finally hydrolyzes to obtain the trifluoroacetyl aniline hydrate hydrochloride of 4 chlorine of product 2 in acid condition by the trifluoroacetyl group N pivaloyl groups aniline of 4 chlorine 2.Present invention n-BuLi makees alkali, is converted to the lithium chloride solution of the high economic value of comparison substantially with after in hydrochloric acid, is easily recycled processing, can reduce sewage disposal difficulty;Make raw material using cheap trifluoro-acetyl chloride, production cost can be reduced.
priorityDate 2015-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452357894
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID11676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514216
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579125
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433062181
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414009909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450422860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID433294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86253369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448478793
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414866235
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559052
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450906005
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21885828
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID11676
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141298206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID158800333
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8870
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6577
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535515
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID82501
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449788384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457282502

Total number of triples: 44.